WAFE
DEAD

Serial Number

87643472

Owner

Rapid Dose Therapeutics Inc.

Filing Date

Oct 12, 2017

Add to watchlist:

No watchlists yet
View on USPTO

WAFE Trademark

Serial Number: 87643472

WAFE is a trademark filed by Rapid Dose Therapeutics Inc. on October 12, 2017. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 7 (Machinery), Class 9 (Computers & Electronics), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 29 (Meats & Processed Foods), Class 32 (Light Beverages). The application is currently no longer active.

Owner Contact Info

Rapid Dose Therapeutics Inc. (27 trademarks)

Suite 401
Burlington, Ontario L7N2G3 , CA

Entity Type: 03

Trademark Details

Filing Date

October 12, 2017

Registration Date

Not Registered

Goods & Services

Turnkey operations in the field of the manufacturing to the order and specification of others of pharmaceutical products, orally administrable products, dermatologically administrable products, nutritional products, biologically ingestible products for mammals, vitamin related products, orally administrable compositions, rapid release carriers, nanonized therapeutics, caffeine based products, physical energy enhancing products, mental energy enhancing products, wellness products, sleep enhancing products, wafers, gum, lozenges, orally dissolvable strips, tablets, capsules, ointments and solutions

Equipment for the manufacture of pharmaceutical products, orally administrable products, dermatologically administrable products, nutritional products, biologically ingestible products for mammals, vitamin related products, orally administrable compositions, rapid release carriers, nanonized therapeutics, caffeine based products, physical energy enhancing products, mental energy enhancing products, wellness products, sleep enhancing products, wafers, gum, lozenges, orally dissolvable strips, tablets, capsules, ointments, solutions, namely, production line equipment; Equipment for the development of pharmaceutical products, orally administrable products, dermatologically administrable products, nutritional products, biologically ingestible products for mammals, vitamin related products, orally administrable compositions, rapid release carriers, nanonized therapeutics, caffeine based products, physical energy enhancing products, mental energy enhancing products, wellness products, sleep enhancing products, wafers, gum, lozenges, orally dissolvable strips, tablets, capsules, ointments, solutions, namely, production line equipment; Equipment for research in the area of pharmaceutical products, orally administrable products, dermatologically administrable products, nutritional products, biologically ingestible products for mammals, vitamin related products, orally administrable compositions, rapid release carriers, nanonized therapeutics, caffeine based products, physical energy enhancing products, mental energy enhancing products, wellness products, sleep enhancing products, wafers, gum, lozenges, orally dissolvable strips, tablets, capsules, ointments, solutions, namely, production line equipment; Laboratory equipment related to pharmaceutical products, orally administrable products, dermatologically administrable products, nutritional products, biologically ingestible products for mammals, vitamin related products, orally administrable compositions, rapid release carriers, nanonized therapeutics, caffeine based products, physical energy enhancing products, mental energy enhancing products, wellness products, sleep enhancing products, wafers, gum, lozenges, orally dissolvable strips, tablets, capsules, ointments, solutions, namely, production line equipment

Caffeine based products, namely, caffeine-containing edible wafers and edible films

Equipment for the manufacture of pharmaceutical products, orally administrable products, dermatologically administrable products, nutritional products, biologically ingestible products for mammals, vitamin related products, orally administrable compositions, rapid release carriers, nanonized therapeutics, caffeine based products, physical energy enhancing products, mental energy enhancing products, wellness products, sleep enhancing products, wafers, gum, lozenges, orally dissolvable strips, tablets, capsules, ointments, solutions, namely, production line equipment

Delivery platforms, namely, edible wafers and edible films

Constituents, namely, chemicals, plant extracts, film-forming polymers, plasticizers, and flavoring agents used in the manufacture of pharmaceutical products, orally administrable products, dermatologically administrable products, nutritional products, biologically ingestible products for mammals, vitamin related products, orally administrable compositions, rapid release carriers, nanonized therapeutics, caffeine based products, physical energy enhancing products, mental energy enhancing products, wellness products, sleep enhancing products, wafers, gum, lozenges, orally dissolvable strips, tablets, capsules, ointments, and solutions

Chemical Slurry used in the manufacture of pharmaceutical products, orally administrable products, dermatologically administrable products, nutritional products, biologically ingestible products for mammals, vitamin related products, orally administrable compositions, rapid release carriers, nanonized therapeutics, caffeine based products, physical energy enhancing products, mental energy enhancing products, wellness products, sleep enhancing products, wafers, gum, lozenges, orally dissolvable strips, tablets, capsules, ointments and solutions; Constituents, namely, chemicals, plant extracts, film-forming polymers, plasticizers, and flavoring agents used in the manufacture of pharmaceutical products, orally administrable products, dermatologically administrable products, nutritional products, biologically ingestible products for mammals, vitamin related products, orally administrable compositions, rapid release carriers, nanonized therapeutics, caffeine based products, physical energy enhancing products, mental energy enhancing products, wellness products, sleep enhancing products, wafers, gum, lozenges, orally dissolvable strips, tablets, capsules, ointments, and solutions

Consulting in the field of the medical and health risks, and benefits related to pharmaceutical products, orally administrable products, dermatologically administrable products, nutritional products, biologically ingestible products for mammals, vitamin related products, orally administrable compositions, rapid release carriers, nanonized therapeutics, caffeine based products, physical energy enhancing products, mental energy enhancing products, wellness products, sleep enhancing products, wafers, gum, lozenges, orally dissolvable strips, tablets, capsules, ointments and solutions

Physical energy enhancing products, namely, natural chemical drinks

Consulting in the field of scientific and medical research and new product development related to pharmaceutical products, orally administrable products, dermatologically administrable products, nutritional products, biologically ingestible products for mammals, vitamin related products, orally administrable compositions, rapid release carriers, nanonized therapeutics, caffeine based products, physical energy enhancing products, mental energy enhancing products, wellness products, sleep enhancing products, wafers, gum, lozenges, orally dissolvable strips, tablets, capsules, ointments and solutions

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Aug 19, 2019 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Aug 16, 2019 ABN2
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 19, 2019 TCCA
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 17, 2019 GNFN
FINAL REFUSAL E-MAILED
Jan 17, 2019 GNFR
FINAL REFUSAL WRITTEN
Jan 17, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 28, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 28, 2018 CRFA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 28, 2018 CHAN
ASSIGNED TO LIE
Nov 28, 2018 ALIE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 18, 2018 TCCA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 18, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 18, 2018 GNRN
NON-FINAL ACTION E-MAILED
May 18, 2018 GNRT
NON-FINAL ACTION WRITTEN
May 18, 2018 CNRT
ASSIGNED TO EXAMINER
May 8, 2018 DOCK
ASSIGNED TO EXAMINER
Nov 2, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 20, 2017 NWOS